Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corey M Frederick

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 30, 2016
Obtaining i.v. fosfomycin through an expanded-access protocolCorey M Frederick, Jennifer Burnette, Laura Aragon, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2024
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infectionsLourdes R Menendez Alvarado, Alice Margulis Landayan, Kelsey N Williams, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 30, 2016
Obtaining i.v. fosfomycin through an expanded-access protocolCorey M Frederick, Jennifer Burnette, Laura Aragon, et al.
The Journal of Antimicrobial Chemotherapy|May 8, 2024
Impact of removing ESBL status labelling from culture reports on the use of carbapenems for non-bacteraemic patients diagnosed with ESBL-positive urinary tract infectionsLourdes R Menendez Alvarado, Alice Margulis Landayan, Kelsey N Williams, et al.
Pageof 1